Publications, Pharmaceutical

Microbial integrity testing for preservative-free drug formulations

Preservative-free formulation can protect patients from the adverse effects of additives and is a growing trend in eye care and nasal drug products.

This paper presents a new tip seal integrity test – TSIT 2.0 – that provides a reasonable and representative challenge for preservative-free solutions with respect to their ability to safeguard microbial integrity. The test uses three germs rather than pseudomonas aeruginosa alone and involves repeated submersion of the discharge orifice during actuation. It is simple, and test duration is relatively short with results generated over a 10-day period. Experimental data are presented to illustrate the application of the new TSIT 2.0 test to an eyedropper. The test is the culmination of a long series of experiments and the results confirm its efficacy for testing the ability of antimicrobial measures to preserve microbial integrity.

Download Publication
3 Jun 2019

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More

This Might Also Be of Interest

1 Sep 2022

In Vitro and In Vivo Assessment of Regional Nasal Deposition using Scintigraphy from ...

Publications, Pharmaceutical, Device Innovations, Product Solutions

Read More
12 Jul 2022

Nasal Drug Delivery: Beyond Hayfever

Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
12 Jul 2022

Digital Health and Digital Therapeutics: Where are we heading and why?

Webinars, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
5 Jul 2022

Drug, Device, Digital: Reimagined Healthcare

Webinars, Pharmaceutical, Innovation & Insights, Brand Differentiation, Market Insights, Product Solutions

Read More
1 10 11 12 13 14 27
Back To Top